Normal view MARC view ISBD view

Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists.

Callahan, Margaret K

Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists. [electronic resource] - Seminars in oncology Aug 2015 - 573-86 p. digital

Publication Type: Journal Article; Review

ISSN: 1532-8708

Standard No.: 10.1053/j.seminoncol.2015.05.008 doi

Subjects--Topical Terms:
Animals
Antibodies--pharmacology
Antibodies, Monoclonal--pharmacology
Biomarkers--metabolism
CTLA-4 Antigen--antagonists & inhibitors
Humans
Ipilimumab
Neoplasms--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)